Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Retained Earnings (2010 - 2026)

Geron's (GERN) quarterly Retained Earnings came in at -$1.9 billion in Q2 2026, down 3.74% year-over-year from -$1.9 billion in Q2 2025, and down 0.9% quarter-over-quarter from -$1.9 billion in Q1 2026.

Analysis

Geron (GERN) Retained Earnings (2010 - 2026) Analysis & Trends

Geron has disclosed Retained Earnings across 17 years of filings, most recently posting -$1.9 billion for Q2 2026.

  • In Q2 2026, Retained Earnings fell 3.74% year-over-year to -$1.9 billion; the TTM figure through Jun 2026 stood at -$1.9 billion (down 3.74% YoY), while the FY2025 annual figure was -$1.9 billion, down 4.71% from the prior year.
  • Retained Earnings came in at -$1.9 billion for Q2 2026 at Geron, down from -$1.9 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$1.3 billion in Q1 2022 to a low of -$1.9 billion in Q2 2026.
  • Average Retained Earnings over 5 years is -$1.6 billion, with a median of -$1.7 billion recorded in 2024.
  • Year-over-year, Retained Earnings declined 14.63% in 2024 and declined 3.74% in 2026.
  • Over 5 years, Retained Earnings stood at -$1.4 billion in 2022, then declined by 13.03% to -$1.6 billion in 2023, then decreased by 10.93% to -$1.8 billion in 2024, then declined by 4.71% to -$1.9 billion in 2025, then slipped by 1.1% to -$1.9 billion in 2026.
  • Per Business Quant data, the three most recent Retained Earnings figures were -$1.9 billion in Q2 2026, -$1.9 billion in Q1 2026, and -$1.9 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 558.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -6.33 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 20.97 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 5.13 Bn
10 Geron 914.60 Mn 613.75 Mn - -1.88 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.88 Bn
Mar 31, 2026 -1.86 Bn
Dec 31, 2025 -1.86 Bn
Sep 30, 2025 -1.83 Bn
Jun 30, 2025 -1.81 Bn
Mar 31, 2025 -1.79 Bn
Dec 31, 2024 -1.77 Bn
Sep 30, 2024 -1.75 Bn
Jun 30, 2024 -1.72 Bn
Mar 31, 2024 -1.65 Bn
Dec 31, 2023 -1.60 Bn
Sep 30, 2023 -1.55 Bn
Jun 30, 2023 -1.50 Bn
Mar 31, 2023 -1.45 Bn
Dec 31, 2022 -1.41 Bn
Sep 30, 2022 -1.37 Bn
Jun 30, 2022 -1.33 Bn
Mar 31, 2022 -1.30 Bn
Dec 31, 2021 -1.27 Bn
Sep 30, 2021 -1.24 Bn